Related Experiment Videos
Skeletal manifestations in cutaneous T-cell lymphomas
Archives of Dermatology
|July 1, 1982
Summary
Cutaneous T-cell lymphoma (CTCL) can cause skeletal disease, including osteolytic and osteoblastic lesions, and osteoporosis. Tumor cells may produce factors that activate bone resorption, leading to these manifestations.
Area of Science:
- Oncology
- Hematology
- Pathology
Background:
- Cutaneous T-cell lymphoma (CTCL) is a diverse group of extranodal T-cell lymphomas.
- Skeletal involvement in CTCL is considered uncommon, with varied clinical presentations.
Observation:
- This study presents three cases of CTCL with distinct skeletal manifestations: osteolytic lesions, osteoblastic lesions, and diffuse osteoporosis.
- Hypercalcemia was observed in two of the three patients.
- Tumor cells from two patients secreted osteoclast-activating factors, correlating with bone resorption.
Findings:
- CTCL can manifest in bone through osteolytic, osteoblastic, or osteoporotic changes.
- Tumor cells in some CTCL patients may produce humoral bone-resorbing factors.
- These factors are similar to those produced by activated normal lymphocytes.
Implications:
- The findings suggest a potential mechanism for skeletal involvement in CTCL via T-cell subsets producing bone-resorbing factors.
- Understanding these mechanisms is crucial for managing skeletal complications in CTCL patients.
- Further research may elucidate the specific T-cell subsets involved in CTCL bone disease.